首页    期刊浏览 2024年11月29日 星期五
登录注册

文章基本信息

  • 标题:Prognostic Value of Drinking Status and Aldehyde Dehydrogenase 2 Polymorphism in Patients With Head and Neck Squamous Cell Carcinoma
  • 本地全文:下载
  • 作者:Daisuke Kawakita ; Isao Oze ; Satoyo Hosono
  • 期刊名称:Journal of Epidemiology
  • 印刷版ISSN:0917-5040
  • 电子版ISSN:1349-9092
  • 出版年度:2016
  • 卷号:26
  • 期号:6
  • 页码:292-299
  • DOI:10.2188/jea.JE20140240
  • 出版社:Japan Epidemiological Association
  • 摘要:Background: The association between alcohol drinking, aldehyde dehydrogenase 2 ( ALDH2 ) polymorphism, and survival in patients with head and neck squamous cell carcinoma (HNSCC) remains unclear. Methods: We performed a retrospective cohort study of 267 HNSCC patients at Aichi Cancer Center. Of these, 65 patients (24%) were non-drinkers, 104 (39%) were light drinkers (ethanol <46 g or <5 days/week), 46 (17%) were moderate drinkers (ethanol intake 46–68 g/day and ≥5 days/week), and 52 (20%) were heavy drinkers (ethanol intake ≥69 g and ≥5 days/week). The prognostic value of pre-treatment drinking status and ALDH2 polymorphism was investigated using multivariate proportional hazard models. Results: Drinking status was associated with disease-free survival (DFS) in HNSCC patients, with marginal statistical significance (5-year DFS: 67.9% [95% confidence interval {CI}, 53.8–78.4%] for non-drinkers, 57.6% [95% CI, 47.4–66.6%] for light drinkers, 46.1% [95% CI, 30.8–60.1%] for moderate drinkers, and 43.5% [95% CI, 29.3–56.9%] for heavy drinkers; P = 0.088). However, this association lost significance when multivariate analyses were adjusted for established prognostic factors. ALDH2 genotype was not significantly associated with DFS in HNSCC patients (5-year DFS: 85.7% [95% CI, 53.9–96.2%] for Lys/Lys, 56.2% [95% CI, 47.4–64.1%] for Glu/Lys, and 50.5% [95% CI, 40.3–59.7%] for Glu/Glu; P = 0.154). After stratification by ALDH2 genotype, we observed a significant positive dose-response relationship between drinking status and DFS in HNSCC patients with ALDH2 Glu/Glu ( P trend = 0.029). Conclusions: In this study, we identified a significant positive dose-response relationship between pre-treatment drinking status and DFS in HNSCC patients with ALDH2 Glu/Glu. To confirm this association, further study is warranted.
  • 关键词:alcohol drinking;ALDH2;head and neck cancer;squamous cell carcinoma;survival
国家哲学社会科学文献中心版权所有